Medical/Pharmaceuticals
Everest Medicines Announces Half-Year 2021 Interim Results
SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Everest Medicines
2021-08-30 22:15
5749
Everest Medicines Announces Up to HK$100 million Share Repurchase Program
SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced t...
2021-08-30 22:03
4894
Approval to Market Sofwave(TM) in South Korea
Key Regulatory Milestone in Company's International Growth Strategy for Unrivaled Ultrasound Technology Treating Fine Lines and Wrinkles YOQNEAM, Israel, Aug. 30, 2021 /PRNewswire/ -- Sofwave Medical LTD, today announced it has received approval from the Korean Ministry of Foods and Drug Safety ...
2021-08-30 20:30
3078
Zamst Announces Sponsorship with Wilfredo León Venero, a Polish Pro Volleyball Player
TOKYO, Aug. 30, 2021 /PRNewswire/ -- Nippon Sigmax Co., Ltd., a company owning "Zamst," a brand of athletic braces and care products headquartered inTokyo, Japan, announced a global sponsorship agreement with Wilfredo León Venero, men's professional volleyball player playing for the SIR Safety Pe...
2021-08-30 14:00
3981
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
STATE COLLEGE, Pa., Aug. 30, 2021 /PRNewswire/ -- NeuExcell Therapeutics ( www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $10+ million Series Pre-A financing round. The round was led by Co-Win Ventures, joined by other institutional investors Yua...
2021-08-30 13:00
2338
Alphamab Oncology Reports 2021 Interim Results and Business Highlights
SUZHOU, China, Aug. 30, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK), announced the company's interim results for the six months ended on June 30, 2021, and highlighted recent progress and upcoming milestones. Dr. Ting Xu, Chairman and CEO of Alphamab Oncology, commented, "In 2021 ...
2021-08-30 10:51
4711
Kenya Grants Emergency Use Authorization for the INDICAID(TM) COVID-19 Rapid Antigen Test
HONG KONG, Aug. 30, 2021 /PRNewswire/ -- PHASE Scientific announces that its INDICAID™ COVID-19 Rapid Antigen Test (INDICAID™) has received Emergency Use Authorization from the Ministry of Health (MOH) of the Republic ofKenya on 17 August 2021. The authorization enables the test to be used in Ken...
2021-08-30 09:00
4888
Innovent to Present New Data on Sintilimab and Other Molecules at the European Society for Medical Oncology (ESMO) Congress 2021
SAN FRANCISCO and SUZHOU, China, Aug. 30, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...
2021-08-30 08:00
4387
Hope Medicine Inc. Announced Dr. Henri Nico Doods as Chief Executive Officer
SHANGHAI, Aug. 30, 2021 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed'), a clinical stage innovative biopharmaceutical company, has recently announced that the former President and Head of Research & Clinical Development, Dr.Henri Nico Doods, will serve as the company's Chief Executive Officer. Dr...
2021-08-30 08:00
8224
MediCap Sdn Bhd Achieves Over 50% of the RM2,000,000 Equity Crowdfunding Goal to Expand 5-in-1 Health Hubs
PETALING JAYA, Malaysia, Aug. 27, 2021 /PRNewswire/ -- MediCap Sdn Bhd (MediCap) has amassed RM1,025,000 in equity crowdfunding, over 50% of the minimum goal ofRM2,000,000 through MyStartr, Malaysia's leading equity crowdfunding platform approved by the Malaysia Security Commission, in a bid to ...
2021-08-27 09:00
3956
Innovent and Bolt Biotherapeutics Announce Collaboration to Develop Three New Oncology Boltbody™ ISAC Programs
SAN FRANCISCO and SUZHOU, China, Aug. 27, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...
2021-08-27 08:00
5770
Lynk Pharmaceuticals announced the completion of Series B financing of $50 million
HANGZHOU, China, Aug. 27, 2021 /PRNewswire/ -- Lynk Pharmaceuticals CO., LTD (hereinafter referred to as "Lynk Pharmaceuticals"), an innovative pharmaceutical R&D company, today announced that it has successfully completed Series B financing of$50 million, with Lilly Asia Ventures (LAV) as lead ...
2021-08-27 08:00
6299
JNCCN Study Reveals Neuroendocrine Tumor Mortality Patterns to Inform Treatment Decisions
Population–based cohort study from Canada is first to describe patterns of mortality, both cancer-related and otherwise, for people with different types of NETs. PLYMOUTH MEETING, Pa., Aug. 27, 2021 /PRNewswire/ -- Among all patients with neuroendocrine tumors (NETs), the risk of dying of cancer...
2021-08-27 03:30
2199
Insilico Medicine and 4B Technologies Announce Strategic Collaboration in Advancing Novel Drug Discovery for Neurodegenerative Diseases
SHANGHAI, Aug. 27, 2021 /PRNewswire/ -- Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery company, and4B Technologies Co., Ltd. ("4B Technologies"), a leading end-to-end innovative biopharmaceutical company focusing on nervous system diseases, signed...
2021-08-27 03:22
32018
Everest Medicines Announces First Person Dosed in Global Phase 3 Registration Trial of Sacituzumab Govitecan-Hziy in China for Metastatic Urothelial Cancer
SHANGHAI, Aug. 26, 2021 /PRNewswire/ -- Everest Medicines
2021-08-26 21:40
5801
Modern Chinese Medicine Announces Year 2021 Interim Results
PERFORMANCE HIGHLIGHTS * Revenue increased by 8.8% to RMB171.8 million * Gross profit increased by 10.4% to RMB78.6 million * Profit after tax increased by 10.5% to approximately RMB44.1 million * The increase in revenue was primarily driven by the surge in revenue generated from the sales...
2021-08-26 20:46
5756
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800
INOVIO's global Phase 3 efficacy trial receives authorization to proceed from Brazil; other countries to follow INOVIO to conduct INNOVATE Phase 3 efficacy trial with partner Advaccine in areas of world in need of COVID-19 vaccines PLYMOUTH MEETING, Pa., Aug. 26, 2021 /PRNewswire/ -- INOVIO (NAS...
2021-08-26 20:00
3957
RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights
TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-08-26 19:56
7616
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant
TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-08-26 19:50
3957
Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)
HYDERABAD, India, Aug. 26, 2021 /PRNewswire/ -- Sai Life Sciences, a leading
globalContract Research, Development & Manufacturing Organization
2021-08-26 19:19
3998
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 309 media titles]
2026-05-19 18:10
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 308 media titles]
2026-05-19 23:59
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 290 media titles]
2026-05-18 15:30
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 281 media titles]
2026-05-20 09:15Most Read
NYSE Content Update: Lincoln International Pops by 13% in First Day of Trade
2026-05-21 21:04
6824
Scienjoy Holding Corporation Reports Unaudited First Quarter 2026 Financial Results
2026-05-21 20:30
6752
/C O R R E C T I O N -- The American Chamber of Commerce in Singapore (AmChamSG)/
2026-05-21 12:14
6269
NYSE Content Update: Armada Raises $230 Million, Boosts Valuation to $2 Billion
2026-05-19 21:02
6202
